Trial Profile
The Effect of Sodium Oxybate in Patients With Chronic Fatigue Syndrome
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2022
Price :
$35
*
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Chronic fatigue syndrome
- Focus Therapeutic Use
- 14 Dec 2022 Status changed from recruiting to withdrawn prior to enrolment.
- 04 Dec 2014 Planned End Date changed from 1 Jul 2015 to 1 Dec 2015, according to ClinicalTrials.gov record.
- 16 Sep 2014 New trial record